Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
186.95
-1.32 (-0.70%)
At close: Apr 2, 2026, 4:00 PM EDT
187.25
+0.30 (0.16%)
After-hours: Apr 2, 2026, 4:53 PM EDT

Jazz Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23
11,50910,4447,4677,657
Market Cap Growth
33.38%39.87%-2.49%-
Enterprise Value
14,49412,38110,5907,657
Last Close Price
186.95170.00123.15123.00
PE Ratio
--29.1114.2420.16
Forward PE
7.817.675.726.29
PEG Ratio
0.140.550.370.50
PS Ratio
2.702.451.842.00
PB Ratio
2.662.421.82-
P/TBV Ratio
2.682.401.99-
P/FCF Ratio
8.878.055.507.17
P/OCF Ratio
8.497.705.357.01
EV/Sales Ratio
3.402.902.602.00
EV/EBITDA Ratio
8.4546.547.696.29
EV/EBIT Ratio
14.24-28.7814.7813.23
EV/FCF Ratio
11.179.557.807.17
Debt / Equity Ratio
1.011.011.49-
Debt / EBITDA Ratio
20.3320.334.47-
Debt / FCF Ratio
4.174.174.53-
Net Debt / Equity Ratio
0.690.690.77-
Net Debt / EBITDA Ratio
11.1511.152.29-
Net Debt / FCF Ratio
2.292.292.32-
Asset Turnover
0.360.360.68-
Inventory Turnover
1.121.121.86-
Quick Ratio
1.461.463.57-
Current Ratio
1.861.864.46-
Return on Equity (ROE)
-8.47%-8.47%27.36%-
Return on Assets (ROA)
-2.06%-2.06%14.25%-
Return on Invested Capital (ROIC)
-3.03%-3.03%21.32%-
Return on Capital Employed (ROCE)
-4.22%-4.22%13.06%-
Earnings Yield
-3.09%-3.44%7.02%4.96%
FCF Yield
11.27%12.42%18.19%13.95%
Buyback Yield / Dilution
7.61%7.61%8.41%-
Total Shareholder Return
7.61%7.61%8.41%-
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q